Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Deflu Medical Device is a Chinese medical device manufacturer specializing in advanced drug delivery systems, particularly for diabetes management. The company develops and produces smart insulin pen injectors, including digital eco smart insulin pens, automatic smart injection pens, high-precision micro-dosing pens, and hidden needle systems. These devices feature digital dose tracking, connectivity options like Bluetooth or USB, and integration with mobile health applications to improve insulin dose accuracy and patient adherence. Jiangsu Deflu Medical Device serves the global healthcare market, providing localized and cost-effective solutions for individuals with type 1 and type 2 diabetes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Deflu Medical Device.